These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35534236)

  • 1. Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis.
    Floro S; Carandini T; Pietroboni AM; De Riz MA; Scarpini E; Galimberti D
    Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35534236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis.
    Sun M; Liu N; Xie Q; Li X; Sun J; Wang H; Wang M
    Mult Scler Relat Disord; 2021 Jun; 51():102870. PubMed ID: 33819724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis.
    Talaat F; Abdelatty S; Ragaie C; Dahshan A
    Neurol Sci; 2023 Sep; 44(9):3243-3252. PubMed ID: 36988727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.
    Hinsinger G; Galéotti N; Nabholz N; Urbach S; Rigau V; Demattei C; Lehmann S; Camu W; Labauge P; Castelnovo G; Brassat D; Loussouarn D; Salou M; Laplaud D; Casez O; Bockaert J; Marin P; Thouvenot E
    Mult Scler; 2015 Sep; 21(10):1251-61. PubMed ID: 25698171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis.
    Momtazmanesh S; Shobeiri P; Saghazadeh A; Teunissen CE; Burman J; Szalardy L; Klivenyi P; Bartos A; Fernandes A; Rezaei N
    Rev Neurosci; 2021 Aug; 32(6):573-595. PubMed ID: 33594840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis.
    Comabella M; Deutschmann C; Midaglia L; Schierack P; Martínez J; Roggenbuck D; Montalban X
    Mult Scler; 2021 Aug; 27(9):1455-1457. PubMed ID: 33327838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.
    Gil-Perotin S; Castillo-Villalba J; Cubas-Nuñez L; Gasque R; Hervas D; Gomez-Mateu J; Alcala C; Perez-Miralles F; Gascon F; Dominguez JA; Casanova B
    Front Neurol; 2019; 10():1008. PubMed ID: 31608004
    [No Abstract]   [Full Text] [Related]  

  • 9. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
    De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M
    Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
    Ning L; Wang B
    PLoS One; 2022; 17(9):e0274565. PubMed ID: 36103562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
    Cantó E; Reverter F; Morcillo-Suárez C; Matesanz F; Fernández O; Izquierdo G; Vandenbroeck K; Rodríguez-Antigüedad A; Urcelay E; Arroyo R; Otaegui D; Olascoaga J; Saiz A; Navarro A; Sanchez A; Domínguez C; Caminero A; Horga A; Tintoré M; Montalban X; Comabella M
    Mult Scler; 2012 Jul; 18(7):983-90. PubMed ID: 22183936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.
    Sellebjerg F; Royen L; Soelberg Sørensen P; Oturai AB; Jensen PEH
    Mult Scler; 2019 Oct; 25(11):1444-1451. PubMed ID: 30113249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF chitinase 3-like-1 association with disability of primary progressive MS.
    Pérez-Miralles F; Prefasi D; García-Merino A; Gascón-Giménez F; Medrano N; Castillo-Villalba J; Cubas L; Alcalá C; Gil-Perotín S; Gómez-Ballesteros R; Maurino J; Álvarez-García E; Casanova B
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32611760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoclonal band versus chitinase-3-like protein-1 in CSF of newly diagnosed relapsing remitting multiple sclerosis.
    Samaha DY; Zeitoun YA; Fouad NT; Abdel Aziz AA; Saad MA
    Egypt J Immunol; 2023 Jan; 30(1):42-48. PubMed ID: 36591957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
    Correale J; Fiol M
    Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.
    Schneider R; Bellenberg B; Gisevius B; Hirschberg S; Sankowski R; Prinz M; Gold R; Lukas C; Haghikia A
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33172960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.
    Thouvenot E; Hinsinger G; Demattei C; Uygunoglu U; Castelnovo G; Pittion-Vouyovitch S; Okuda D; Kantarci O; Pelletier D; Lehmann S; Marin P; Siva A; Lebrun C
    Mult Scler; 2019 Apr; 25(5):669-677. PubMed ID: 29564952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF chitinase proteins in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis.
    Lucchini M; De Arcangelis V; Piro G; Nociti V; Bianco A; De Fino C; Di Sante G; Ria F; Calabresi P; Mirabella M
    Mol Neurobiol; 2023 Jan; 60(1):36-50. PubMed ID: 36215027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.